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Background and purpose   The degree of postoperative pain is 
usually moderate to severe following knee arthroplasty. We inves-
tigated the efficacy of local administration of analgesics into the 
operating area, both intraoperatively and postoperatively.
Methods      40  patients  undergoing  unicompartmental  knee 
arthroplasty (UKA) were randomized into 2 groups in a double–
blind  study  (ClinicalTrials.gov  identifier:  NCT00653926).  In 
group A (active), 200 mg ropivacaine, 30 mg ketorolac, and 0.5 
mg epinephrine (total volume 106 mL) were infiltrated intraop-
eratively into the soft tissue, while in group P (placebo), no injec-
tions were given. 21 hours postoperatively, 150 mg ropivacain, 30 
mg ketorolac, and 0.1 mg epinephrine were injected intraarticu-
larly via a catheter in group A, whereas patients in group P were 
injected with the same volume of saline (22 mL). 
Results   Median hospital stay was shorter in group A than in 
group P: 1 (1–6) days as opposed to 3 (1–6) days (p < 0.001). Post-
operative pain in group A was statistically significantly lower at 
rest after 6 h and 27 h and on movement after 6, 12, 22, and 27 
h. Morphine consumption was statistically significantly lower in 
group A for the first 48 h, resulting in a lower frequency of nausea, 
pruritus,  and  sedation.  Postoperatively,  there  were  improved 
functional scores (Oxford knee score and EQ–5D) in both groups 
relative to the corresponding preoperative values. 
Interpretation   Local injection of analgesics periarticularly at 
the end of the operation and intraarticularly at 21 h postopera-
tively provided excellent pain relief and earlier home discharge 
following UKA. There was a high degree of patient satisfaction in 
both groups after 6 months (Clinical Trials.gov: NCT 00653926).

Postoperative  pain  is  often  severe  after  knee  arthroplasty 
(Wang et al. 2002). Traditionally, this has been managed with 
epidural  analgesia,  continuous  peripheral  nerve  blocks,  or 
parental opioid drugs. Although epidural analgesia is effica-
cious (Axelsson et al. 2005), side effects and some rare but 
major complications such as spinal hemorrhage and spinal 
infection have recently led to questioning of its routine use, 
specifically in older women (Moen et al. 2004). Peripheral 
nerve blocks provide good analgesia, but in order to control 
pain effectively, it may be necessary to block the sciatic, femo-
ral, and obturator nerves (McNamee et al. 2002), which can be 
technically demanding. Parenteral opioids are associated with 
side effects. This has led to a search for new strategies in order 
to avoid the problems of regional analgesia or opioids, and to 
minimize the complications.
Recently, a local infiltration analgesia (LIA) technique was 
developed by Kerr and Kohan in Sydney, Australia (Röstlund 
and Kehlet 2007, Kerr and Kohan 2008). With this LIA tech-
nique, a long–acting local anesthetic (ropivacaine), a non–ste-
roidal anti–inflammatory drug (ketorolac), and epinephrine are 
infiltrated periarticularly intraoperatively and via an intraar-
ticular catheter postoperatively. Effective pain relief with early 
mobilization and reduced hospital stay was reported.
Minimally invasive techniques for arthroplasty have become 
increasingly popular, especially for unicompartmental knee 
arthroplasty  (UKA)  in  medial  non–inflammatory  arthritis. 
Together with an intraoperative multimodal analgesia program 
and rapid mobilization, the minimally invasive technique is 
believed to reduce the hospital stay further (Beard et al. 2002, 
Reilly et al. 2005, Carlsson et al. 2006, Berend and Lombardi 
2007). However, the specific role of the LIA technique has not 
been fully investigated in double–blind studies.
The  main  aim  of  this  double–blind  study  was  to  evalu-
ate whether intra- and postoperative administration of ropi-
vacaine, ketorolac, and epinephrine into the operating field 
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from each patient before the start of the study. Surgery was 
performed at the Department of Orthopedics, Örebro Univer-
sity Hospital from September 2005 through March 2007 and 
patients were followed for 6 months after surgery. 
The  hospital  pharmacy  randomized  the  patients  into  2 
groups with 20 patients in each, using computer–generated 
randomized numbers. Group A (active) received a multimodal 
injection intraoperatively and postoperatively while group P 
(placebo) received no injection intraoperatively and a saline 
injection postoperatively as detailed below. On the day before 
surgery or on the morning of surgery, the surgeon called the 
hospital pharmacy to receive the group randomization. The 
patients, the 2 study investigators, the study physiotherapist, 
and all the staff concerned with the postoperative care of the 
patients were blinded. Since the operating surgeons were not 
blinded, they did not take any part in patient care after comple-
tion of the operation.
Anesthesia
All  patients  received  diazepam  (10  mg)  orally  1  h  before 
planned surgery and all operations were performed under gen-
eral anesthesia. When designing this study, we decided not to 
use spinal or epidural anesthesia in order to be able to assess 
differences in early postoperative pain and mobilization more 
accurately, and to ensure blinding of the patients as to treat-
ment. Cloxacillin (1 g) was given intravenously before surgery 
and at 8, 16, and 24 h postoperatively. For thrombo–prophy-
laxis, Dalteparin (5,000 IU) was administered subcutaneously 
once each evening for 10 days, starting on the evening before 
surgery.
Surgery
All  operations  were  performed  using  a  minimally  invasive 
technique. The same technique was used in both groups, and 
all patients received the Link Endo–Model Sled Prosthesis 
(Link Sweden AB, Akersberga, Sweden). A tourniquet was 
used in all patients.
Pain management
In group A, 200 mg ropivicaine, 30 mg ketorolac, and 0.5 mg 
epinephrine (total volume 106 mL) were infiltrated by the sur-
geon into the soft tissues periarticularly during the operation 
in the following way. Before inserting the components, 20–30 
mL was injected into the posterior capsule and before closure 
Figure 1. Flow chart for the study.
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Catheter dislocation 
Excluded  (n = 1) 
Conversion to total  
knee arthroplasty
200 mg ropivacaine (100 mL)
30 mg ketorolac (1 mL) 
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were morphine consumption, pain intensity, and 
side effects. In an attempt to assess the safety of 
the technique, knee function and patient satis-
faction scores were also determined for up to 6 
months after surgery.
Patients and methods
The study protocol was approved by the regional 
ethics  committee  (May  4,  2005,  EudraCt  no. 
2005–000685–39)  and  the  Swedish  Medical 
Products Agency, and conducted in accordance 
with the Declaration of Helsinki (ClinicalTrials.
gov identifier: NCT00653926).
57  consecutive  patients  scheduled  for 
unicompartmental  knee  arthroplasty  (UKA) 
because of osteoarthritis were screened for eli-
gibility. The inclusion criteria were: age 20–80 
years, ASA physical status I–III, and mobility 
indicating  normal  preoperative  mobilization. 
Exclusion  criteria  included  known  allergy  or 
intolerance  to  one  of  the  study  drugs,  serious 
liver,  heart  or  renal  disease,  chronic  pain,  or 
bleeding disorder. 
Randomization and blinding
57 patients were assessed for eligibility and 17 
were excluded prior to randomization; see the 
flow chart for details (Figure 1). Thus, 40 patients 
were enrolled in this randomized double–blind 
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of the wound, the rest was injected into the capsule incision, 
the synovium, the ligament, and the subcutaneous tissue. In 
group P, no injections were given. All patients had a tunnelled 
intraarticular multihole 20–G catheter placed at the end of the 
operation by the surgeon. No drain was placed in the wound. 
A compression bandage and ice packs were applied during 
the first 6 h. A patient–controlled analgesia (PCA) pump with 
morphine (1–mg bolus with 6–min lockout time) was con-
nected intravenously, which was used as rescue medication 
by all patients. All patients received 1 g paracetamol orally 4 
times a day, starting on the preoperative morning. After 21 h, 
150 mg ropivicaine, 30 mg ketorolac, and 0.1 mg epinephrine, 
total volume 22 mL, were injected intraarticularly via the cath-
eter in group A and a similar volume of saline was injected in 
group P. Pain assessments were made using a 100–mm visual 
analog scale (VAS) and, at 24 h, if pain at rest was < 40 on 
the VAS during a 2–h period, the PCA pump was discontin-
ued and paracetamol (1 g) and tramadol (50 mg) orally were 
administered up to 4 times daily as required. The intraarticular 
catheter was removed after 24 h and the tip of the catheter was 
sent for culture.
Mobilization and home discharge
The first attempt at mobilization was made 6 h postoperatively, 
when the patient was encouraged to stand up and to walk 2–3 
steps. If unsuccessful, mobilization was attempted again on 
the following day. Patients were discharged when they ful-
filled the discharge criteria (see below). After discharge, the 
patients  were  asked  to  complete  a  questionnaire  regarding 
postoperative pain on days 1, 3, and 14.
Outcome measures
Hospital stay. The time to discharge (where day 0 was the day 
of the operation) was assessed by a physician and the study 
physiotherapist (who were unaware of the group randomiza-
tion) according to the following criteria: mild pain (VAS < 30) 
sufficiently controlled by oral analgesics, ability to walk with 
elbow crutches, ability to climb 8 stairs, ability to eat and 
drink, and no evidence of any surgical complication.
Pain. Assessment of pain (VAS) was done at 3 h, 6 h, 12 h, 
21 h, 22 h (i.e. 1 h after injection of the test drug in the knee 
catheter), 27 h, on days 3 and 14, and at 3 and 6 months post-
operatively. Pain was assessed both at rest and with motion 
(60 degrees of knee flexion).
Analgesic  consumption.  Morphine  consumption  was 
recorded during 0–6 h, 6–24 h, and 24–48 h postoperatively. 
Oral analgesic consumption was recorded during 0–24 h, 24–
48 h, 48–96 h, and 96–168 h.
Surgical outcomes. The physiotherapist recorded the abil-
ity to walk with a walking frame 6 h postoperatively. Knee 
extension and flexion were assessed preoperatively, at 27 h, 
at discharge, on day 3, and at 3 and 6 months postoperatively. 
Patient satisfaction during the first 24 postoperative hours and 
after 7 days was rated. Oxford knee score was determined 
preoperatively, at 2 weeks, and 3 and 6 months postopera-
tively. Oxford knee score is a validated 12–item knee ques-
tionnaire that scores patients from 12 points (the best possible) 
to 60 points (the worst possible) (Jahromi et al. 2004). The 
EuroCol (EQ–5D) questionnaire was filled in preoperatively 
and at 6 months postoperatively. EuroCol (EQ–5D) is a stan-
dardized instrument for use as a measure of health outcome 
(Fransen and Edmonds 1999). It provides a single index value 
from 0 to 1 where 0 represents poor health and 1 represents 
perfect health.
All complications and adverse events were registered intra-
operatively  and  postoperatively,  as  well  as  after  discharge. 
Any hospital re–admissions during the 6–month follow–up 
period were also recorded.
Statistics
A power analysis was done prior to the start of the study using 
length of hospital stay (LOS) as the primary endpoint. In a pilot 
study on 8 patients, the LOS for the intervention group was 
found to be 3.1 (SD 1.3). In a similar group of patients, oper-
ated earlier without the LIA technique, the mean LOS was 5.5 
(SD 1.5) days. With an α of 0.05 and a β of 0.2, an expected 
reduction of 1.5 days in the treatment group, and a standard 
deviation of 1.5, 17 patients would be required in each group. 
Assuming that there would be a somewhat greater standard 
deviation in the control group, 20 patients were included in 
each group of the study. 
The Mann–Whitney–U test was used for analysis of the 
primary endpoint (LOS) since the data were not found to be 
normally  distributed.  Results  are  presented  as  median  and 
95% CI. The VAS was assessed as a supportive parameter and 
analyzed as if it was a primary endpoint. Mann–Whitney–U 
test was used to assess median pain scores and the p–values 
were corrected using the Bonferroni–Holm method. The other 
secondary endpoints (morphine consumption, knee function 
scores,  and  patient  satisfaction  scores)  were  also  analyzed 
using  the  Mann–Whitney–U  test.  Dichotomous  data  were 
analyzed using the chi–square test or Fisher’s exact test, as 
appropriate. A p–value of < 0.05 was considered to be statisti-
cally significant.
Results
Patients
Of the 40 patients enrolled in the study, 2 were excluded: 1 in 
group A due to catheter disconnection and 1 in group P due 
to intraoperative conversion to total knee arthroplasty. Thus, 
38 patients completed the study. Patient characteristics were 
similar in both groups (Table 1). 
Primary endpoint
Hospital stay. Analysis of the results when including all 40 
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protocol principle) did not reveal any statistically significant 
differences. Median postoperative hospital stay was less in 
group A (n = 19) than in group P (n = 19): 1 (1–6) days vs. 3 
(1–6) days (p < 0.001), i.e. there was a median difference of 2 
(CI 95% 1–2) days (Figure 2). In group A, 13/19 patients were 
discharged during the first postoperative day as compared to 
2/19 in group P (p < 0.001). During the first 2 postoperative 
days, 17/19 patients were discharged in group A and only 6/19 
were discharged in group P (p < 0.001). 5 patients (2 patients 
in group A and 3 patients in group P) had a prolonged hospital 
stay due to pain, and were discharged after the third postop-
erative day. 
Secondary endpoints
Pain relief. At rest, VAS pain score was lower in group A than 
in group P at 6 h (p = 0.003) and 27 h (p = 0.004) (Figure 3). 
At 6 months, 3 patients had registered pain in group A (5, 6, 
and 21) whereas in group P all patients had a VAS score of 0. 
With movement (Figure 4), VAS pain scores were lower in 
group A than in group P at 6, 12, and 22 h (all with p < 0.001) 
and at 27 h (p = 0.001). At 6 months, all patients in both groups 
had a VAS score of 0. 
Table 1. Demographic data and duration of surgery, mean (SD)
  Group A  Group P
 
No. of females/males  9/10  10/9
Age, years  66 (5)  64 (6)
Weight, kg  87 (11)  85 (11)
Height, cm  171 (11)  170 (12)
BMI  30 (3)  30 (1)
ASA physical status I/II  6/13  9/10
Operation time, min  92 (13)  86 (11)
       
Group A (active): intraoperative, periarticular infiltration; 
Group P (placebo): no intraoperative infiltration.
ASA physical status I: normal health; and II: mild systemic disease.
Figure 2. Day 1 represents the first postoperative day.
    Group  A  (active)=  intraoperative,  periarticular  infiltration:  200  mg 
ropivacaine, 30mg ketorolac and 0.5 mg epinephrine; postoperative, 
intraarticular injection: 150 mg ropivacaine, 30 mg ketorolac and 0.1 
mg epinephrine.
   Group P (placebo)= no intraoperative infiltration and postoperative, 
intraarticular injection: 22 mL saline.
  The median discharge times are shown: Group A = day 1 and in 
Group P = day 3 (p<0.001); Number of patients discharged after 2 
days: 17/19 in Group A vs. 6/19 in Group P (p<001).
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Figure 3. Postoperative pain at rest. VAS scores are presented as median and inter-
quartile range (IQR). * p = 0.003 (6 h); p = 0.004 (27 h).
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Consumption of analgesics
Median morphine consumption was lower in group A than in 
group P: 21 (0–68) mg as opposed to 67 (17–126) mg during 
the first 48 h postoperatively (p < 0.001). From 24 h to 48 
h postoperatively, there were only 2 patients in group A that 
required  morphine,  as  compared  to12  patients  in  group  P 
(p < 0.001). There was no statistically significant difference 
in total tramadol consumption between the groups during the 
first 7 postoperative days. Acta Orthopaedica 2009; 80 (2): 213–219  217
Surgical outcomes
16 of the 19 patients in group A and 9 of 
the 19 in group P could walk with a frame 
6 h after surgery. 
There was a statistically significant dif-
ference between groups A and P in knee 
extension and knee flexion 27 h postop-
eratively: 5(0–20) degrees vs. 10 (0–20) 
degrees (p = 0.002) for extension and 90 
(75–110) degrees vs. 80 (45–100) degrees 
(p = 0.001) for flexion (Table 2). No statis-
tically significant differences were found 
between the groups at 3 days, 3 months, 
and 6 months postoperatively.
The median values of patient satisfac-
tion scores varied between 3 and 4 and 
there  were  no  significant  differences 
between the groups at 24 h and at 7 days. 
There was a statistically significant dif-
ference in Oxford knee score between the 
groups at 3 months, with higher scores in 
group A than in group P. No statistically 
significant difference in EQ–5D value was 
found at 6 months postoperatively.
Adverse effects
There were no major surgical complica-
tions in any of the patients. There were 
higher  incidences  of  nausea  (10  vs.  4), 
pruritus (4 vs. 0), and sedation (4 vs. 0) in 
group P than in group A (p < 0.05).
There were 3 positive cultures from the 
catheter tips, all with coagulase–negative 
Staphylococcus. The patient in group A 
with  positive  culture  had  increased  C–
reactive protein (CRP) of short duration 
without  any  increase  in  leukocytes.  No 
antibiotic therapy was given and no clini-
cal signs of infection were found during 
the follow–up period. The other 2 patients 
in group P had no increase in CRP or leu-
kocytes. No patients were re–admitted for 
any complications during the 6 months of 
follow–up.
Discussion
In  one  recent  study  on  total  knee 
arthroplasty,  continuous  femoral  nerve 
block was compared with the LIA tech-
nique (Toftdahl et al. 2007). The authors 
found  reduced  opioid  consumption  and 
Figure 4. Postoperative pain on movement. VAS scores are presented as median and inter-
quartile range (IQR). * p < 0.001 (6 h); p < 0.001 (12 h); p < 0.001 (22 h); p = 0.001 (27 h).
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Table 2. Mobilization and patient satisfaction
Outcome  Group A  Group P  p–value
  Median (range)  n  Median (range)  n
Knee extension (degrees) 
   preop.    5 (0–20)   19  10 (0–15)   19  0.09 
   27 h postop.    5 (0–20)   18  10 (0–25)   19  0.002 
   discharge  10 (0–20)   17  10 (0–25)   19  0.07 
   3 days postop.  10 (0–25)   19  10 (0–25)   19  1 
   3 months postop.    5 (0–15)   18    5 (0–15)   18  0.8 
   6 months postop.    0 (0–10)   18    0 (0–19)   18  0.7 
Knee flexion (degrees) 
   preop.  120 (95–135)   19  125 (90–135)   19  0.5 
   27 h postop.     90 (75–110)   18     80 (45–100)   19  0.001 
   discharge     90 (70–110)   17     90 (50–95)   19  0.5 
   3 days postop.     80 (60–115)   19     90 (60–95)   19  0.2 
   3 months postop.  120 (100–130)   18  120 (105–130)   18  0.6 
   6 months postop.  125 (95–135)   18  125 (105–130)   18  0.9 
Patient satisfaction 
   1 day postop.  4 (2–4)   19  3 (1–4)   19  0.2 
   7 days postop.  3 (2–4)   19  3 (1–4)   19  0.4 
Oxford knee score 
   preop.  40 (27–52)   19  42 (33–50)   19  0.4 
   14 days postop.  31 (14–44)   19  32 (14–36)   19  0.2 
   3 months postop.  20.5 (13–42)   19  14.5 (12–30)   18  0.01 
   6 months postop.  17.5 (12–35)   18  13 (12–21)   18  0.08 
EQ-5D 
   preop.  0.66 (0.09–0.80)  19  0.20 (–0.08–0.73)   19  0.08 
   6 months postop.  1 (0.66–1)   18  1 (0.8–1)   18  0.06
n: number of patients who participated varied depending on patients’ ability to cooperate. 
Knee extension and knee flexion: significant difference between the groups at 27 h.
Oxford knee score: 12 (the best possible) to 60 (the worst possible).
Preop. score vs. 14 days postop. scores: p = 0.05 (group A); p < 0.001 (group P).
Preop. score vs. 3-month and 6-month postop. scores: p = 0.001 (group A); p < 0.001 
(group P).
EQ-5D health outcome: 1 = perfect health; 0 = poor health; and negative values = very 
poor health outcome.
Preop. values vs. 6-month values: p = 0.001 (group A); p < 0.001 (group P). 218  Acta Orthopaedica 2009; 80 (2): 213–219
improved pain scores in the LIA group. When correctly per-
formed by experienced anesthesiologists, nerve blocks may 
be a good alternative for prolongation of postoperative pain 
relief. However, the simplicity of LIA and its high success rate 
could have an advantage over peripheral nerve blocks in this 
setting. 
Unicompartmental  arthroplasty  with  minimally  invasive 
technique  results  in  less  operative  trauma  than  total  knee 
arthroplasty.  However,  moderate–to–severe  pain  remains 
a  common  problem.  In  an  open  pilot  study  (Beard  et  al. 
2002) and a single–blind study (Reilly et al. 2005), a modi-
fied  LIA  technique  with  only  infiltration  of  ropivacaine, 
ketorolac, and adrenaline intraoperatively was tested during 
unicompartmental  arthroplasty  and  gave  promising  results. 
The infiltration technique in combination with oral NSAIDs 
and opioids resulted in a high degree of patient satisfaction, 
good pain relief, and early discharge with no major complica-
tions. In both studies, Redivac drain was used during the first 
14–18 hours. In contrast to the above studies, we have tested 
the LIA technique in a double–blind study with a combination 
of  ropivacine,  ketorolac,  and  adrenaline  administered  both 
intraoperatively and on day 1 postoperatively without postop-
erative Redivac drain. Both the intraoperative infiltration and 
the postoperative intraarticular injection of this combination 
of analgesics via the catheter resulted in an acceptable degree 
of pain relief during the initial postoperative period; in addi-
tion, an increased range of knee movement resulted in early 
discharge. In addition to improved pain relief, we also found a 
lower consumption of rescue analgesics, which in turn resulted 
in a lower incidence of opioid–related side effects (including 
sedation, pruritus, and nausea) when LIA was used rather than 
placebo.
One  consequence  of  improved  pain  relief  is  a  natural 
improvement in mobilization. This can, however, have det-
rimental effects sometimes, as was seen in a study by Lom-
bardi (Lombardi et al. 2004) on total knee arthroplasty. These 
authors found a “rebound effect” on postoperative pain during 
the first 2 postoperative days in the intervention group. A pos-
sible explanation for this finding may be higher activity levels 
achieved from better pain control and less sedation, which 
could in turn result in increased pain subsequently. Alterna-
tively, patients may experience a delay in the onset of pain 
postoperatively,  which  can  be  interpreted  as  greater  pain 
intensity. In our study, we could not find any evidence of such 
a rebound effect.
Although  good  analgesia  can  be  achieved  using  differ-
ent techniques, it is important that the time in hospital is not 
prolonged. Thus, our aim was to achieve good pain relief and 
early mobilization without prolonging recovery or hospital 
discharge. Since hospital discharge can be affected by several 
non–medical factors, we used an objective method to assesss 
whether the patient was ready to be sent home. These crite-
ria have been used by other authors as a way of objectively 
assessing  recovery  and  discharge  (Gupta  et  al.  1999).  Our 
findings show that there was a substantial reduction in hospital 
stay without having a negative effect on patient satisfaction. 
Other authors have reported similar results (Reilly et al. 2005, 
Berend and Lombardi 2007).
Although pain relief was better in the LIA group, this did not 
translate into improved knee function except at 27 h postoper-
atively. This can be explained in several ways. The scales used 
for assessment of knee function may not be sensitive enough 
to detect differences after knee surgery. Discharge time, used 
in an appropriate way, appeared to be a valuable tool. Func-
tional  assessment  by  Oxford  knee  score  should  have  been 
done earlier postoperatively instead of after 2 weeks, when 
pain intensity was low, even in the placebo group—which may 
explain the absence of any differences in Oxford knee score 
between the groups.
 We found no differences between the groups in the EuroQol 
preoperatively and after 6 months. Thus, data from both instru-
ments measuring the functional assessment support the find-
ings of others that early discharge is safe and unicompartmental 
techniques (Beard et al. 2002, Reilly et al. 2005, Berend and 
Lombardi 2007).
We used a combination of ropivacain, ketorolac, and epi-
nephrine for LIA. It is possible that a combination of ropiva-
caine and ketorolac alone would have been adequate to pro-
vide a similar degree of pain relief. However, we were con-
cerned about LA toxicity when injecting 200 mg ropivacaine 
locally due to its rapid absorption from the tissues and there-
fore added arenaline to the solution. In addition, adrenaline 
has been shown to have an alpha–2 agonistic effect similar to 
clonidine (Niemi and Breivik 2002) and we thought that we 
might be able to reduce pain further by using this combina-
tion.
 Although the use of oral non–steroidal anti–inflammatory 
drugs (NSAIDs) in a multimodal analgesic regime may have 
reduced pain intensity further and rescue analgesic consump-
tion, we decided not to use these for several reasons. We used 
ketorolac as part of the multimodal analgesic treatment with 
LIA, which has been found previously to be efficacious (Beard 
et al. 2002, Reilly et al. 2005, Toftdahl et al. 2007). However, 
combination of ketorolac with another oral NSAID may result 
in systemic toxicity. In addition, regional NSAID injections 
have been shown to provide better analgesia than when they 
are administered systemically (Reuben and Connelly 1995).
We conclude that the LIA technique can be strongly recom-
mended for postoperative analgesia after unicompartmental 
knee arthroplasty. Further studies would be certainly valuable 
to determine the best components in the mixture of drugs to be 
used in the LIA technique.
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